Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Condition:   Diabetic Nephropathy Interventions:   Drug: Canagliflozin;   Drug: Placebo Sponsor:   Mitsubishi Tanabe Pharma Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials